Publicaciones en colaboración con investigadores/as de Universitat de València (9)

2021

  1. Update of the recommendations for the determination of biomarkers in colorectal carcinoma. National Consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology

    Revista Espanola de Patologia, Vol. 54, Núm. 1, pp. 41-54

2020

  1. Update of the recommendations for the determination of biomarkers in colorectal carcinoma: National Consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology

    Clinical and Translational Oncology, Vol. 22, Núm. 11, pp. 1976-1991

2019

  1. Exploratory findings from a prematurely closed international, multicentre, academic trial: RAVELLO, a phase III study of regorafenib versus placebo as maintenance therapy after first-line treatment in RAS wild-type metastatic colorectal cancer

    ESMO Open, Vol. 4, Núm. 4

2017

  1. Efficacy of trifluridine and tipiracil (TAS-102) versus placebo, with supportive care, in a randomized, controlled trial of patients with metastatic colorectal cancer from Spain: results of a subgroup analysis of the phase 3 RECOURSE trial

    Clinical and Translational Oncology, Vol. 19, Núm. 2, pp. 227-235

2015

  1. Safety and activity of the first-in-class Sym004 anti-EGFR antibody mixture in patients with refractory colorectal cancer

    Cancer Discovery, Vol. 5, Núm. 6, pp. 598-609

2014

  1. An open-label phase II study evaluating the safety and efficacy of ramucirumab combined with mFOLFOX-6 as first-line therapy for metastatic colorectal cancer

    Oncologist, Vol. 19, Núm. 4, pp. 350-351

  2. Open-label, multicentre expansion cohort to evaluate imgatuzumab in pre-treated patients with KRAS-mutant advanced colorectal carcinoma

    European Journal of Cancer, Vol. 50, Núm. 3, pp. 496-505

2012

  1. Guidelines for biomarker testing in colorectal carcinoma (CRC): A national consensus of the Spanish Society of Pathology (SEAP) and the Spanish Society of Medical Oncology (SEOM)

    Clinical and Translational Oncology, Vol. 14, Núm. 10, pp. 726-739

2002

  1. Pemetrexed in bladder, head and neck, and cervical cancers

    Seminars in Oncology, Vol. 29, Núm. 6 SUPPL. 18, pp. 69-75